Unknown OBSERVATIONAL NCT00406900

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Sponsor: Ludwig-Maximilians - University of Munich

Conditions Melanoma Metastatic Disease Radiotherapy

Interventions Treatment of metastatic disease

Updated 6 times since 2017 Last updated: Dec 5, 2006 Started: Jan 31, 1999 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Melanoma and Metastatic Disease, this trial is ongoing. The trial is conducted by Ludwig-Maximilians - University of Munich and has accumulated 6 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ludwig-Maximilians - University of Munich

Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany